Source: Eur Respir J 2012; 39: 913-918
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Barceló A., Piérola J., de la Peña M., Esquinas C., Sanchez-de la Torre M., Ayllón O., Alonso A., Agusti A.G.N., Barbè F.. Day–night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea. Eur Respir J 2012; 39: 913-918

Member's Comments

No comment yet.

Related content which might interest you: Sleep apnea and endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 814s Year: 2006 Obstructive sleep apnoea is not associated with endothelial dysfunction in a sleep clinic population Source: Eur Respir J 2003; 22: Suppl. 45, 567s Year: 2003 Endothelial dysfunction in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Impact of obstructive sleep apnea and obesity on endothelial dysfunction in children Source: Virtual Congress 2020 – Respiratory physiology and sleep: from neonates to adults Year: 2020 Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004 Napping as a sleep apnea marker Source: Eur Respir J 2006; 28: Suppl. 50, 196s Year: 2006 Pathophysiology of central sleep apnea Source: Annual Congress 2005 - Central sleep apnoea Year: 2005 Endothelial function in obstructive sleep apnea syndrome Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Signalling pathways in intermittent hypoxia and in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Cerebral oxygenation during REM sleep in obstructive sleep apnoea is associated with daytime neuropsychological function Source: Eur Respir J 2004; 24: Suppl. 48, 444s Year: 2004 Microparticles and vascular dysfunction in obstructive sleep apnoea Source: Eur Respir J 2014; 44: 207-216 Year: 2014 A prospective polysomnographic study on the evolution of complex sleep apnoea Source: Eur Respir J 2011; 38: 329-337 Year: 2011 Endothelial dysfunction in patients with obstructive sleep apnea independent of metabolic syndrome Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 CPAP therapy improves endothelial dysfunction in obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Eur Respir J 2004; 24: Suppl. 48, 565s Year: 2004 Circulating microparticles and endothelial dysfunction in obstructive sleep apnea syndrome Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Obstructive sleep apnea Source: Respipedia Article Year: 2017 Respiratory abnormalities during sleep Source: Annual Congress 2007 - PG21 - Diagnostic and therapeutic aspects of respiratory disorders during sleep Year: 2007 Influence of micropaticles harvested from patients affected by obstructive sleep apnea syndrome on endothelial function and vascular reactivity Source: Annual Congress 2009 - Pathogenesis of sleep-disordered breathing Year: 2009 Relationship of oxidative stress and endothelial dysfunction in sleep apnoea Source: Eur Respir J 2011; 37: 873-879 Year: 2011